The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved...
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to...
On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses....
The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as...
On July 13, 2020, the AIIMS (All India Institute of Medical Sciences) Patna began human trials of COVID-19 on 10 volunteers. Highlights The first dose was given to...
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes...
The World Health Organisation (WHO) has given its pre-qualification to Typbar Typhoid Conjugate Vaccine (TVC) developed by Hyderabad based Bharat Biotech for global use. Typbar TCV is world’s...
Hyderabad-based vaccines manufacturer Bharat Biotech has announced a breakthrough in developing the world’s first Zika vaccine by developing two candidates. In this regard, the pharmaceutical company has submitted...
